| Literature DB >> 26572448 |
Guodong Wang1, Chunyan Liu2, Jun Liu3, Bo Liu3, Ping Li2, Guozheng Qin2, Yanghui Xu2, Ke Chen3, Huixia Liu4, Kaoshan Chen5.
Abstract
In this study, we reported the anticancer efficacy of exopolysaccharide (EPS) derived from Trichoderma pseudokoningii, on human breast cancer MCF-7 cells. Our results showed that EPS inhibited the proliferation of MCF-7 cells and induced lactic dehydrogenase release by inducing apoptosis and cell arrest at S phase. Further study revealed that EPS-induced apoptosis of MCF-7 cells was associated with alteration of nuclear morphology, disruption of mitochondrial membrane potential and accumulation of intracellular reactive oxygen species. Sequentially, EPS increased the activation of caspase-9 and caspase-3 in a dose-dependent manner; however, caspase-8 remained intact. Western blot analysis revealed that EPS increased the ratio of Bax/Bcl-2 and promoted the release of cytochrome c into the cytoplasm. Taken together, these findings provided evidence that EPS induced the apoptosis of MCF-7 cells through an intrinsic mitochondrial apoptotic pathway and that EPS may therefore be considered as an effective adjuvant agent against human breast cancer.Entities:
Keywords: Apoptosis; Cell cycle arrest; DCFH-DA (PubChem CID: 77718); Dimethyl sulfoxide (PubChem CID: 679); Exopolysaccharide; Hoechst 33258 (PubChem CID: 5491656); Human breast cancer; JC-1 (PubChem CID: 5492929); Propidium iodide (PubChem CID: 104981); Trichoderma pseudokoningii
Mesh:
Substances:
Year: 2015 PMID: 26572448 DOI: 10.1016/j.carbpol.2015.09.108
Source DB: PubMed Journal: Carbohydr Polym ISSN: 0144-8617 Impact factor: 9.381